Financial information regarding reportable operating segments |
Summarized financial information regarding our reportable operating segments for the three months ended is shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In millions |
|
Engine |
|
Distribution |
|
Components |
|
Power Systems |
|
New Power |
|
Total Segments |
|
|
|
|
Three months ended September 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
$ |
2,063
|
|
|
$ |
2,232
|
|
|
$ |
2,220
|
|
|
$ |
773
|
|
|
$ |
45
|
|
|
$ |
7,333
|
|
|
|
|
|
Intersegment sales |
|
716
|
|
|
7
|
|
|
483
|
|
|
576
|
|
|
5
|
|
|
1,787
|
|
|
|
|
|
Total sales |
|
2,779
|
|
|
2,239
|
|
|
2,703
|
|
|
1,349
|
|
|
50
|
|
|
9,120
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research, development and engineering expenses |
|
140
|
|
|
13
|
|
|
87
|
|
|
62
|
|
|
46
|
|
|
348
|
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
28
|
|
|
20
|
|
|
17
|
|
|
10
|
|
|
(5) |
|
|
70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
3
|
|
|
4
|
|
|
4
|
|
|
3
|
|
|
—
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russian suspension costs(1)
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment EBITDA |
|
363
|
|
|
225
|
|
|
297
|
|
(2) |
193
|
|
|
(96) |
|
|
982
|
|
|
|
|
|
Depreciation and amortization(3)
|
|
51
|
|
|
29
|
|
|
95
|
|
|
30
|
|
|
10
|
|
|
215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended October 3, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
$ |
1,961 |
|
|
$ |
1,952 |
|
|
$ |
1,347 |
|
|
$ |
688 |
|
|
$ |
20 |
|
|
$ |
5,968 |
|
|
|
|
|
Intersegment sales |
|
617 |
|
|
7 |
|
|
446 |
|
|
476 |
|
|
3 |
|
|
1,549 |
|
|
|
|
|
Total sales |
|
2,578 |
|
|
1,959 |
|
|
1,793 |
|
|
1,164 |
|
|
23 |
|
|
7,517 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research, development and engineering expenses |
|
97 |
|
|
10 |
|
|
78 |
|
|
55 |
|
|
26 |
|
|
266 |
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
61 |
|
|
15 |
|
|
10 |
|
|
11 |
|
|
(3) |
|
|
94 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
3 |
|
|
2 |
|
|
1 |
|
|
1 |
|
|
— |
|
|
7 |
|
|
|
|
|
Segment EBITDA |
|
391 |
|
|
192 |
|
|
253 |
|
|
134 |
|
|
(58) |
|
|
912 |
|
|
|
|
|
Depreciation and amortization(3)
|
|
53 |
|
|
28 |
|
|
44 |
|
|
29 |
|
|
5 |
|
|
159 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) See NOTE 3, "RUSSIAN OPERATIONS," to our Condensed Consolidated Financial Statements for additional information.
|
|
|
|
|
(2) Includes $45 million of costs related to the acquisition and integration of Meritor and $10 million of costs associated with the planned separation of our filtration business.
|
|
|
|
|
(3) Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in the Condensed Consolidated Statements of Net Income as Interest expense. A portion of depreciation expense is included in Research, development and engineering expenses.
|
|
Summarized financial information regarding our reportable operating segments for the nine months ended is shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In millions |
|
Engine |
|
Distribution |
|
Components |
|
Power Systems |
|
New Power |
|
Total Segments |
|
|
|
|
|
Nine months ended September 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
$ |
6,204
|
|
|
$ |
6,590
|
|
|
$ |
5,214
|
|
|
$ |
2,190
|
|
|
$ |
106
|
|
|
$ |
20,304
|
|
|
|
|
|
|
Intersegment sales |
|
2,103
|
|
|
19
|
|
|
1,427
|
|
|
1,522
|
|
|
17
|
|
|
5,088
|
|
|
|
|
|
|
Total sales |
|
8,307
|
|
|
6,609
|
|
|
6,641
|
|
|
3,712
|
|
|
123
|
|
|
25,392
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research, development and engineering expenses |
|
365
|
|
|
39
|
|
|
236
|
|
|
184
|
|
|
121
|
|
|
945
|
|
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
131
|
|
(1) |
57
|
|
|
54
|
|
|
31
|
|
|
(12) |
|
|
261
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
8
|
|
|
9
|
|
|
7
|
|
|
5
|
|
|
—
|
|
|
29
|
|
|
|
|
|
|
Russian suspension costs(2)
|
|
33
|
|
(3) |
55
|
|
|
5
|
|
|
19
|
|
|
—
|
|
|
112
|
|
|
|
|
|
|
Segment EBITDA |
|
1,177
|
|
|
632
|
|
|
969
|
|
(4) |
411
|
|
|
(243) |
|
|
2,946
|
|
|
|
|
|
|
Depreciation and amortization(5)
|
|
151
|
|
|
86
|
|
|
187
|
|
|
92
|
|
|
25
|
|
|
541
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended October 3, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
$ |
5,776 |
|
|
$ |
5,692 |
|
|
$ |
4,627 |
|
|
$ |
1,999 |
|
|
$ |
77 |
|
|
$ |
18,171 |
|
|
|
|
|
|
Intersegment sales |
|
1,752 |
|
|
22 |
|
|
1,312 |
|
|
1,330 |
|
|
5 |
|
|
4,421 |
|
|
|
|
|
|
Total sales |
|
7,528 |
|
|
5,714 |
|
|
5,939 |
|
|
3,329 |
|
|
82 |
|
|
22,592 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research, development and engineering expenses |
|
288 |
|
|
35 |
|
|
232 |
|
|
172 |
|
|
75 |
|
|
802 |
|
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
278 |
|
|
47 |
|
|
41 |
|
|
32 |
|
|
(1) |
|
|
397 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
7 |
|
|
5 |
|
|
3 |
|
|
3 |
|
|
— |
|
|
18 |
|
|
|
|
|
|
Segment EBITDA |
|
1,147 |
|
|
553 |
|
|
975 |
|
|
399 |
|
|
(169) |
|
|
2,905 |
|
|
|
|
|
|
Depreciation and amortization(5)
|
|
154 |
|
|
88 |
|
|
138 |
|
|
97 |
|
|
17 |
|
|
494 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Includes a $28 million impairment of our joint venture with KAMAZ and $3 million of royalty charges as part of our costs associated with the suspension of our Russian operations. See NOTE 3, "RUSSIAN OPERATIONS," to our Condensed Consolidated Financial Statements for additional information.
|
|
|
|
|
|
(2) See NOTE 3, "RUSSIAN OPERATIONS," to our Condensed Consolidated Financial Statements for additional information.
|
|
|
|
|
|
(3) Includes $31 million of Russian suspension costs reflected in the Equity, royalty and interest income (loss) from investees line above.
|
|
|
|
|
|
(4) Includes $56 million of costs related to the acquisition and integration of Meritor and $15 million of costs associated with the planned separation of our filtration business.
|
|
|
|
|
|
(5) Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in the Condensed Consolidated Statements of Net Income as Interest expense. The amortization of debt discount and deferred costs was $3 million and $3 million for the nine months ended September 30, 2022 and October 3, 2021, respectively. A portion of depreciation expense is included in Research, development and engineering expenses.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Revenue from Segments to Consolidated |
A reconciliation of our total segment sales to total net sales in the Condensed Consolidated Statements of Net Income was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
In millions |
|
September 30, 2022 |
|
October 3, 2021 |
|
September 30, 2022 |
|
October 3, 2021 |
Total segment sales |
|
$ |
9,120
|
|
|
$ |
7,517 |
|
|
$ |
25,392
|
|
|
$ |
22,592 |
|
Elimination of intersegment sales |
|
(1,787) |
|
|
(1,549) |
|
|
(5,088) |
|
|
(4,421) |
|
Total net sales |
|
$ |
7,333
|
|
|
$ |
5,968 |
|
|
$ |
20,304
|
|
|
$ |
18,171 |
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of segment information |
A reconciliation of our segment information to the corresponding amounts in the Condensed Consolidated Statements of Net Income is shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Nine months ended |
In millions |
|
September 30, 2022 |
|
October 3, 2021 |
|
September 30, 2022 |
|
October 3, 2021 |
TOTAL SEGMENT EBITDA |
|
$ |
982
|
|
|
$ |
912 |
|
|
$ |
2,946
|
|
|
$ |
2,905 |
|
|
|
|
|
|
|
|
|
|
Intersegment eliminations and other(1)
|
|
(98) |
|
|
(50) |
|
|
(252) |
|
|
(89) |
|
|
|
|
|
|
|
|
|
|
Less: |
|
|
|
|
|
|
|
|
Interest expense |
|
61
|
|
|
28 |
|
|
112
|
|
|
85 |
|
Depreciation and amortization |
|
215
|
|
|
159 |
|
|
541
|
|
|
494 |
|
INCOME BEFORE INCOME TAXES |
|
608
|
|
|
675 |
|
|
2,041
|
|
|
2,237 |
|
Less: Income tax expense |
|
199
|
|
|
134 |
|
|
502
|
|
|
473 |
|
CONSOLIDATED NET INCOME |
|
409
|
|
|
541 |
|
|
1,539
|
|
|
1,764 |
|
Less: Net income attributable to noncontrolling interests |
|
9
|
|
|
7 |
|
|
19
|
|
|
27 |
|
NET INCOME ATTRIBUTABLE TO CUMMINS INC. |
|
$ |
400
|
|
|
$ |
534 |
|
|
$ |
1,520
|
|
|
$ |
1,737 |
|
|
|
|
|
|
|
|
|
|
(1)Intersegment eliminations and other included $6 million and $47 million of costs associated with the planned separation of our Filtration business for the three and nine months ended September 30, 2022.
|
|
|
|
|
|
|
|
|
|
|